A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.
Clinical trial NCT03238963 · COMPLETED
Trial details
- NCT number
- NCT03238963
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-19
- Primary completion
- 2020-05-14
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.